期刊文献+

非小细胞肺癌组织中MMP-9、TIMP-1表达及意义 被引量:9

Expression and significance of MMP-9,TIMP-1 in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨非小细胞肺癌(non-small cell lung cancer,NSCLC)组织中基质金属蛋白酶9(MMP-9)、组织金属蛋白酶抑制剂-1(TIMP-1)的表达及其生物学行为的关系。方法应用免疫组织化学SP法检测76例NSCLC和癌旁正常组织中MMP-9、TIMP-1的表达,并分析其表达与肺癌组织类型、肿瘤大小、TNM分期、分化程度、淋巴结转移的相关性。结果 MMP-9、TIMP-1在肺癌组织中的阳性表达率明显高于癌旁正常组织(P<0.05)。NSCLC中MMP-9、TIMP-1表达与肿瘤的分化程度、临床分期、淋巴结转移有相关性(P<0.05),与肿瘤病理分型无关(P>0.05)。结论检测NSCLC中组织的MMP-9、TIMP-1的表达对判断肿瘤的恶性程度和预后评估有一定的意义。 Purpose To investigate the correlations of expression and biology behavior of matrix metalloproteinase 9(MMP-9)and tissue inhibitors of metalloproteinase-1(TIMP-1) in non-small cell lung cancer(NSCLC).Methods SP immunohistochemical method was used to detect the expressions of MMP-9 and TIMP-1 in 76 cases of NSCLC and adjacent normal lung tissues,and analyzed the correlation of their expression with histological types of NSCLC,tumor size,TNM staging,differentiation degree and lymph node metastasis.Results The positive expression rates of MMP-9,TIMP-1 in lung cancer tissue were higher than that in the adjacent normal lung tissue(P0.05).MMP-9,TIMP-1 expressions in NSCLC were significantly correlated with TNM stage,differentiations,lymph node metastasis(P0.05),but there were no relationship with tumor pathology classification(P0.05).Conclusion There is certain significance on detection of the expression of MMP-9,TIMP-1 in NSCLC for judging malignant degree and prognosis of tumors.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2011年第10期1084-1086,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 安徽省教育厅自然科学研究项目(KJ2010A183)
关键词 肺肿瘤 非小细胞肺癌 MMP-9 TIMP-1 免疫组织化学 lung neoplasms non-small cell lung cancer MMP-9 TIMP-1 immunohistochemistry
  • 相关文献

参考文献9

二级参考文献77

  • 1李庆昌,王妍,谢成耀,邱雪杉,王恩华.非小细胞肺癌MMP-2、MMP-9、TIMP-1表达及与预后关系研究[J].中国肺癌杂志,2004,7(6):497-500. 被引量:3
  • 2朱少伟,罗光华,张晓膺,郑璐,魏江,朱江.非小细胞肺癌中基质金属蛋白酶-10的表达[J].江苏大学学报(医学版),2007,17(3):247-250. 被引量:7
  • 3Thomas P,Khokha R,Shepherd FA,et al.Diffenrential expression of matrix metalloproteinases and their inbibitors in non-smalll cell lung cancer[J].J Pathol,2000,19(2):150-156.
  • 4Sier CFM,Kubben FJGM,Ganesh S,et al.Tissue lesels of matrix metalloproteinase MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma[M].Br J Cancer,1996,74:413-417.
  • 5Zeng ZS,Hung Y,Cohen AM,Guillem JG.Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9[J].J Clin Oncol,1996,14:3133-3140.
  • 6Sun J, Hemler M E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions [ J ]. Cancer Res,2001,61 (5) : 2276 - 81.
  • 7Jiang Y, Goldberg I D, Shi Y E. Complex roles of tissue inhibitors of metalloproteinases in cancer [ J ]. Oncogene, 2002,21 ( 14 ) : 2245 - 52.
  • 8Shah F D, Shukla S N, Shah P M, et al. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer [ J ]. Indian J Cancer,2009,46 ( 3 ), 194 - 202.
  • 9Biswas C,Zhang Y, DeCastro R, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN ) is a member of the immunoglobulin superfamily[ J]. Cancer Res, 1995, 55(2) : 434 -9.
  • 10Riethdorf S, Reimers N, Assmann V, et al. High incidence of EMMPRIN expression in human tumors [ J ]. Int J Cancer,2006, 119(8) :1800 - 10.

共引文献98

同被引文献107

引证文献9

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部